GHRP-6 may be useful in protecting neurons in the substantia nigra and slowing or preventing the onset ofParkinsons disease
note the peptide's favorable tolerability profile across multiple rodent studies, with no reported organ toxicity at research doses [1,2]
Key Areas of Research: Endocrine: Growth hormone, IGF-1, signaling Metabolic: Lipids, lean tissue, glucose balance Cellular: Proliferation, repair, recovery Systemic: Cardiovascular, viability, healing Together, these findings suggest broad experimental potential for CJC-1295 and Ipamorelin across multiple biological pathways
In reality, no, Ipamorelin does not typically make you hungry
Lot-Linked COAs : Each vials lot number ties directly to third-party HPLC/MS results
Growth hormone deficiency in 'little' mice results in aberrant body composition, reduced insulin-like growth factor-I and insulin-like growth factor-binding protein-3 (IGFBP-3), but does not affect IGFBP-2, -1 or -4